AMTI - Applied Molecular Transport Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

3.896M

Cash

41.77M

Avg Qtr Burn

-20.52M

Short % of Float

2.37%

Insider Ownership

22.61%

Institutional Own.

47.82%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AMT-101 (IL-10 oral agonist) Details Pouchitis	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) +anti-TNFα Details UC (Ulcerative colitis)	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) Details Ulcerative colitis	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) +anti-TNFα Details RA (rheumatoid arthritis)	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-126 (IL-22) Details GI barrier repair	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.